Alan B. Goldsobel

1.8k total citations
47 papers, 730 citations indexed

About

Alan B. Goldsobel is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Alan B. Goldsobel has authored 47 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 22 papers in Pulmonary and Respiratory Medicine and 15 papers in Immunology and Allergy. Recurrent topics in Alan B. Goldsobel's work include Asthma and respiratory diseases (21 papers), Respiratory and Cough-Related Research (16 papers) and Allergic Rhinitis and Sensitization (13 papers). Alan B. Goldsobel is often cited by papers focused on Asthma and respiratory diseases (21 papers), Respiratory and Cough-Related Research (16 papers) and Allergic Rhinitis and Sensitization (13 papers). Alan B. Goldsobel collaborates with scholars based in United States, United Kingdom and Germany. Alan B. Goldsobel's co-authors include Bradley E. Chipps, E. Richard Stiehm, Albert Haas, Eli O. Meltzer, Jose Bardelas, Robert B. Layzer, Harold B. Kaiser, Richard M. Ehrlich, Ronald J. Barr and Roger M. Katz and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and Annals of Neurology.

In The Last Decade

Alan B. Goldsobel

46 papers receiving 688 citations

Peers

Countries citing papers authored by Alan B. Goldsobel

Since Specialization

Citations

This map shows the geographic impact of Alan B. Goldsobel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan B. Goldsobel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan B. Goldsobel more than expected).

Fields of papers citing papers by Alan B. Goldsobel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan B. Goldsobel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan B. Goldsobel. The network helps show where Alan B. Goldsobel may publish in the future.

Co-authorship network of co-authors of Alan B. Goldsobel

This figure shows the co-authorship network connecting the top 25 collaborators of Alan B. Goldsobel. A scholar is included among the top collaborators of Alan B. Goldsobel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan B. Goldsobel. Alan B. Goldsobel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials 2022 ·Annals of Allergy Asthma & Immunology ·Christina E. Ciaccio, Alan B. Goldsobel, Aikaterini Anagnostou, Kirsten Beyer, Thomas B. Casale, A. Deschildre, Montserrat Fernández‐Rivas, Jonathan O’B Hourihane, Marta Krawiec, Phil Lieberman, Amy M. Scurlock, Brian P. Vickery, (unknown), Stephen A. Tilles, Daniel C. Adelman, Kari Brown, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	8
2	Improvements in Cough Severity and Quality of Life in SOOTHE, A Phase 2b, Dose Finding Trial of BLU-5937 in Refractory Chronic Cough 2022 ·(unknown), John A. Smith, Alyn H. Morice, Lorcan McGarvey, Mandel Sher, Alan B. Goldsobel, (unknown), Lewis O. Harvey, (unknown), (unknown), (unknown)	2
3	Improvements in cough severity and cough-related quality of life in a phase 2 trial (RELIEF) with the P2X3 antagonist BLU-5937 in refractory chronic cough (RCC) 2021 ·Surinder S. Birring, John A. Smith, Alyn H. Morice, Mandel Sher, James H. Hull, Alan B. Goldsobel, Sylvain Lanouette, (unknown), (unknown), Catherine M. Bonuccelli	4
4	Prospective trial examining safety and efficacy of microcurrent stimulation for the treatment of sinus pain and congestion 2019 ·SHILAP Revista de lepidopterología ·Alan B. Goldsobel, (unknown), Blake T. Gurfein	7
5	Identification of Peanut-Allergic Participants for Oral Immunotherapy With AR101 Using Clinical Reaction History and Immunologic Markers Without Oral Food Challenge – A Comparison Between RAMSES and PALISADE Trials 2019 ·Journal of Allergy and Clinical Immunology ·Alan B. Goldsobel, Kirsten Beyer, Stacie M. Jones, A. Wesley Burks, Wayne G. Shreffler, Thomas B. Casale, George Du Toit, (unknown), (unknown), Noelle M. Griffin, Daniel C. Adelman, John G. Matthews, Kari Brown, Brian P. Vickery	1
6	Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis 2018 ·PEDIATRICS ·Alan B. Goldsobel	7
7	Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis 2018 ·PEDIATRICS ·Alan B. Goldsobel	1
8	Association of Changes in Air Quality With Bronchitic Symptoms in Children in California, 1993-2012 2017 ·PEDIATRICS ·Alan B. Goldsobel	1
9	Sublingual Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and Asthma: A Systematic Review 2013 ·PEDIATRICS ·Alan B. Goldsobel	17
10	Efficacy of Oral Immunotherapy and Anti-IgE Antibody-Adjunctive Treatment in Patients with Multiple Food Allergies 2013 ·Journal of Allergy and Clinical Immunology ·Tina Dominguez, Shruti P. Wilson, (unknown), Daniela Pineda, Anjuli Mehrotra, (unknown), Alan B. Goldsobel, Michael J. Mulligan, Robert C. Bocian, (unknown), Kari C. Nadeau	1
11	The adult with chronic cough 2012 ·Journal of Allergy and Clinical Immunology ·Alan B. Goldsobel, Pramod S. Kelkar	5
12	Use of Complementary and Alternative Medicine by Food-Allergic Patients 2007 ·PEDIATRICS ·Alan B. Goldsobel	2
13	Efficacy and Safety of Echinacea in Treating Upper Respiratory Tract Infections in Children: A Randomized Controlled Trial 2005 ·PEDIATRICS ·Alan B. Goldsobel	6
14	Risk of Adenoid Hypertrophy in Children with Allergic Rhinitis 2002 ·PEDIATRICS ·Alan B. Goldsobel	5
15	Safety of fexofenadine in children treated for seasonal allergic rhinitis 2001 ·Annals of Allergy Asthma & Immunology ·David F. Graft, (unknown), Alan B. Goldsobel, E.O. Meltzer, (unknown), Joseph B. Long	27
16	SALMETEROL XINAFOATE AS MAINTENANCE THERAPY COMPARED WITH ALBUTEROL IN PATIENTS WITH ASTHMA 1995 ·PEDIATRICS ·(unknown), Alan B. Goldsobel	3
17	MECHANISM OF CARDIOTOXIC ACTIONS OF TERFENADINE 1994 ·PEDIATRICS ·Alan B. Goldsobel	5
18	Bone marrow transplantation in DiGeorge syndrome 1987 ·The Journal of Pediatrics ·Alan B. Goldsobel, Albert Haas, E. Richard Stiehm	43
19	Efficacy of doxepin in the treatment of chronic idiopathic urticaria 1986 ·Journal of Allergy and Clinical Immunology ·Alan B. Goldsobel, Albert S. Rohr, Sheldon C. Siegel, Sheldon L. Spector, Roger M. Katz, (unknown), (unknown), (unknown), James B. Peter, Ronald J. Barr, (unknown)	67
20	The Use of Sodium 2-Mercaptoethane Sulfonate to Prevent Cyclophosphamide Cystitis 1984 ·The Journal of Urology ·Richard M. Ehrlich, (unknown), Alan B. Goldsobel, E. Richard Stiehm	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact